Topiramate
Product Images NDC 45865-963
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 45865-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structured Product Formula For Topiramate (A9eed983 Edf1 4f44 A8ec 568a52f03015 01)
Structured Product Formula For Topiramate (A9eed983 Edf1 4f44 A8ec 568a52f03015 02)
The text describes a figure presenting the cumulative rates for time to the first seizure. The data is divided into two groups, one treated with Topiramate 50 mg/day and the other with Topiramate 400 mg/day. The graph used for the display is a Kaplan-Meier estimate. The x-axis represents time in days and ranges from 0 to 40.*
Topiramate Tablets Usp (A9eed983 Edf1 4f44 A8ec 568a52f03015 03)
The text shows a table that presents the change from baseline to double-blind phase in average monthly migraine period rate for different dosages of topiramate and placebo. There are also values for the standard error and the number of participants in each group. The asterisks indicate statistical significance.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.